Shopping Cart
- Remove All
- Your shopping cart is currently empty
Litifilimab (BIIB059) is a humanizedantibody targeting the plasma cell-like dendritic cell specific antigen (BDCA2) and C-type lectin structural domain family 4, member C (CLEC4C) for the study of cutaneous lupus erythematosus.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $217 | In Stock | |
5 mg | $456 | In Stock | |
10 mg | $728 | In Stock | |
25 mg | $1,080 | In Stock | |
50 mg | $1,480 | In Stock |
Description | Litifilimab (BIIB059) is a humanizedantibody targeting the plasma cell-like dendritic cell specific antigen (BDCA2) and C-type lectin structural domain family 4, member C (CLEC4C) for the study of cutaneous lupus erythematosus. |
Alias | BIIB059, BIIB 059 |
Cas No. | 2407378-48-5 |
Storage | store at low temperature | store at -20°C | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.